Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer

Thomas Horn, Markus Krönke, Isabel Rauscher, Bernhard Haller, Stephanie Robu, Hans Jürgen Wester, Margret Schottelius, Fijs W.B. van Leeuwen, Henk G. van der Poel, Matthias Heck, Jürgen E. Gschwend, Wolfgang Weber, Matthias Eiber, Tobias Maurer

Publikation: Beitrag in FachzeitschriftArtikelBegutachtung

80 Zitate (Scopus)

Abstract

Prostate-specific membrane antigen (PSMA) radioguided surgery leads to a substantial prostate-specific antigen (PSA) reduction in the vast majority of patients with recurrent prostate cancer. A low PSA value and the presence of only one lesion on preoperative imaging with PSMA-ligand positron emission tomography are prognostic factors for a better outcome.

OriginalspracheEnglisch
Seiten (von - bis)517-523
Seitenumfang7
FachzeitschriftEuropean Urology
Jahrgang76
Ausgabenummer4
DOIs
PublikationsstatusVeröffentlicht - Okt. 2019

Fingerprint

Untersuchen Sie die Forschungsthemen von „Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren